Nestle India shares fell on Friday after FSSAI initiated three adjudication cases over alleged violations involving infant nutrition products. The regulator flagged promotional claims on NAN Excella Pro Stage 1 and Lactogen Pro 1 and also found a follow-up formula sample non-conforming for biotin content during laboratory testing.